期刊文献+

双功能试剂与螯合金属元素标记多肽新技术的建立

New Peptide Labeling Technique Based on Bifunctional Reagent and Rare Earth Metal Chelating Tags
下载PDF
导出
摘要 建立了双功能试剂2-[(4-异硫氰基苯基)甲基]-1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(p-SCN-Bn-DOTA)与标准肽段反应的新方法,测定了反应产物与镧系金属Eu(Ⅲ)的螯合效率,探索了其作为靶向探针和蛋白定量标记试剂性能。考察了不同缓冲体系的浓度及pH值、p-SCN-Bn-DOTA量与肽段相对量、反应体系中有机相与水相比例,反应温度与反应时间对偶联效率的影响。实验结果显示:p-SCN-Bn-DOTA量为肽段的32倍,缓冲体系为0.2 mol/L TEAB(pH 8.5),60℃反应60 min,有机相与水相之比为4.4∶1(V/V)时标记效率高;在HCl/Na Ac缓冲体系(pH 4.0)中60℃反应60 min,金属离子鳌合反应效率高达94%。本研究建立了一种新的基于双功能试剂p-SCN-Bn-DOTA的标记方法,并成功用于RGD肽等的标记。 A novel labeling approach with good compatibility based on 2-(4-isothiocyanatobenzyl)-1,4,7,10- tetraazacyclododecane-1,4,7,10-tetraacetic acid (p-SCN-Bn-DOTA) was established. The labeling conditions of p-SCN-Bn-DOTA with standard peptides were optimized, and the labeling efficiency of macrocyclic complex of p-SCN-Bn-DOTA with lanthanide metal ion Eu(Ⅲ) was also investigated. The labeling process was a two-step reaction. The labeling efficiency was affected by several factors including pH, buffer, reaction time, reaction temperature, and ratio of p-SCN-Bn-DOTA to peptide. The optimized conditions were as followed: the first step of labeling reaction was reacted in 0.2 mol/L triethylene diamine (TEAB) ( pH 8.5 ) buffer for 60 rain at 60℃, and the molar ratio of p-SCN-Bn-DOTA with peptide was 32. The second step of rare earth metal chelating was in pH 4.0 HCI/NaAC buffer for 60 min at 60℃. This approach was successfully applied in RGD peptide labeling.
出处 《分析化学》 SCIE EI CAS CSCD 北大核心 2016年第7期1022-1028,共7页 Chinese Journal of Analytical Chemistry
基金 北京市自然科学基金(Nos.7143172,7143173)资助
关键词 双功能试剂 标记 多肽 蛋白定量 质谱 Bifunctional chelating reagents Labeling Peptide Protein quantification Mass spectrometry
  • 相关文献

参考文献31

  • 1Lee S,Xie J, Chen X. Chem. Rev.,2010,110(5) : 3087-3111.
  • 2Kerr T J, McLean J A. Chem. Commun.,2010, 46(30) : 5479-5481.
  • 3Ang C Y, Tan S Y, Zhao Y. Org. Biomol. Chem.,2014,12(27) : 4776-4806.
  • 4Von Wallbrunn A, Holtke C,Ziihlsdorf M, Heindel W, Schafers M,Bremer C. Eur. J. Nucl. Med. MoL Imaging, 2007,34(5) : 745-754.
  • 5邸丽娟,张旭初,张春丽,王荣福.RGD肽类肿瘤受体显像剂的研究进展[J].标记免疫分析与临床,2007,14(1):58-61. 被引量:8
  • 6黄嫣嫣,赵睿.基于靶向多肽探针的蛋白质分析检测新方法[J].分析测试学报,2012,31(9):1184-1190. 被引量:6
  • 7Shiba K. Chem. Soc. Rev.,2010,39( 1) : 117-126.
  • 8Gygi S P, Rist B, Gerber S A, Turecek F, Gelb M H,Aebersold R. Nat. Biotechnol. , 1999,17(10) : 994-999.
  • 9Yao X, Freas A, Ramirez J, Demirev P A, Fenselau C. Anal. Chem.,2001,73(13) : 2836-2842.
  • 10Ong S E, Blagoev B, Kratchmarova I,Kristensen D B, Steen H, Pandey A, Mann M. Mol. Cell. Proteom.,2002, 1(5): 376-386.

二级参考文献141

  • 1李伟.iTRAQ多重化学标记串联质谱技术在比较蛋白质组学中的应用[J].生命的化学,2006,26(5):453-456. 被引量:8
  • 2钱林艺,应万涛,刘新,卢庄,蔡耘,何建勇,钱小红.^(18)O稳定同位素标记定量蛋白质组研究技术的建立与优化[J].分析化学,2007,35(2):161-165. 被引量:9
  • 3Gevaert K,Impens F,Ghesquiere B,van Damme P,Lambrechts A,Vandekerckhove J.Proteomics,2008,8(23-24):4873-4885.
  • 4Kito K,Ito T.Curr.Genomics,2008,9(4):263-274.
  • 5Pan S,Aebersold R,Chen R,Rush J,Goodlett D R,McIntosh M W,Zhang J,Brentnall T A.J.Proteome Res,2009,8(2):787-797.
  • 6Ong S E,Foster L J,Mann M.Methods,2003,29(2):124-130.
  • 7Gygi S P,Rist B,Gerber S A,Turecek F,Gelb M H,Aebersold R.Nat.Biotechnol.,1999,17(10):994-999.
  • 8Li J,Steen H,Gygi S P.Mol.Cell Proteomics,2003,2(11):1198-1204.
  • 9DeSouza L,Diehl G,Rodrigues M J,Guo J,Romaschin A D,Colgan T J,Siu K W.J.Proteome′ Res.2005,4(2):377-386.
  • 10Wiese S,Reidegeld K A,Meyer H E,Warscheid B.Proteomics,2007,7(3):340-350.

共引文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部